Daily Note 12/12/2023 – Market View: Day Ahead, Macro, Stocks, Debt Markets


  •  It was a modestly risk-on session for equity markets yesterday with Europe, the tech heavy Nasdaq and the S&P500 all ending the day marginally in the green, as investors positioned themselves ahead of a busy few days of central bank meetings and economic data releases.
  • This morning, AstraZeneca announced that it has entered into an agreement to acquire Icosavax in a deal that could be worth up to $1.1bn.
  • Treasury yields were mixed yesterday, with investor optimism for the trajectory of interest rates expected to be tested later in the week.